MET and colorectal carcinoma: We also found that both genetic and epigenetic alterations of c-MET/EGFR were associated with immune infiltration, dysfunctional T-cell phenotypes, and poor prognoses of CRC patients, hence adding another layer of prognostic relevance of c-MET/EGFR in CRC.